Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus - Wikidata - awgldk - TriplyDB

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus

http://www.wikidata.org/entity/Q26775640

about

Glucose-regulated protein 78 is an antiviral against hepatitis A virus replication.Inhibitory effect of Japanese rice-koji miso extracts on hepatitis A virus replication in association with the elevation of glucose-regulated protein 78 expression

P2860

Q40170609-DC712486-19D7-4B8F-BC21-DD6D92D4955B Q56396000-76ABD286-090D-401B-BB8B-779A419007EE

P2860

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus

http://www.wikidata.org/entity/Q26775640

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus

@ast

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus

@en

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus

@nl

type

label

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus

@ast

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus

@en

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus

@nl

prefLabel

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus

@ast

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus

@en

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus

@nl

P1433

Q26775640-7058BD45-10FA-425A-ADC0-4054938B9665

P1476

Q26775640-857C67F3-117C-487B-A917-347C1EA106FC

P2093

Q26775640-138E8308-864A-427D-A686-480C2B5EDE01

Q26775640-3B2A4638-29BB-431B-9F6B-76054C7F0580

Q26775640-914038D0-DA1B-4A26-883F-1DA7B801546F

Q26775640-9AF8816F-2571-48BC-9978-9C67D8456CEB

Q26775640-A37A4FE0-E587-4CEC-8FA5-D81E4C17E0BF

Q26775640-A44B538A-AB4E-4B10-BB98-C6A28AC2BB42

Q26775640-EA8A805C-9535-452C-82B8-ADE7A4238215

Q26775640-F7AAD5F7-6CEA-4572-BCB9-F5AF2A3BBE62

P2860

Q26775640-000A42AF-465F-4F3C-9801-A7B07C995F4E

Q26775640-001F01F8-98D6-4C0F-8821-2B38087A067A

Q26775640-066304C9-96D9-49DF-8673-CA995C0E2B8C

Q26775640-0793FD66-EB59-4C0A-8269-B0CA67A50394

Q26775640-0A8B3373-4B9A-4CBD-9C82-FA4E8A53A3D3

Q26775640-0EC53BDE-3B8F-46B8-88E2-27D010617391

Q26775640-116BE90C-7693-446E-95FC-82474A990349

Q26775640-1419428F-806F-4888-95B2-D91574A64226

Q26775640-14D18AD8-F9A8-4845-B812-6F35B2D48851

Q26775640-155F1545-CF1B-4D59-A060-852CDCDB4791

P304

Q26775640-F630321F-2C5D-4672-8FB6-C7B16FAAAA4A

P31

Q26775640-E7D75AC4-7029-4B2A-8E8A-CD18932C688A

P356

Q26775640-401F843A-FB40-477A-8084-26C92A2DC29E

P407

Q26775640-9A2A66FB-0F02-4E7B-8794-D9B6E8543387

P433

Q26775640-B66F8E3F-AC07-4BD0-963C-F7B712B4F049

P478

Q26775640-A2EC2BBD-A029-4CD7-BF62-812727EB100D

P577

Q26775640-AC7E0DDC-B3A7-4F44-9F09-A412DE08BE07

P5875

Q26775640-F68F6773-DA88-48F1-92C9-1B08D6C1E20D

P698

Q26775640-EDD952D7-5FFE-4C5F-A9B1-B05F535C7A4C

P921

Q26775640-EDA60029-8E6D-41DC-BB4C-0FC39CC2665A

P932

Q26775640-264EF9B3-F7D8-4328-AC3F-23194E2F8E54

P356

JCTH.2015.00016

P1433

Journal of clinical and translational hepatology

P1476

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus

@en

P2093

Masato Nakamura

http://www.w3.org/2001/XMLSchema#string

Osamu Yokosuka

http://www.w3.org/2001/XMLSchema#string

Reina Sasaki

http://www.w3.org/2001/XMLSchema#string

Shingo Nakamoto

http://www.w3.org/2001/XMLSchema#string

Shuang Wu

http://www.w3.org/2001/XMLSchema#string

Tatsuo Kanda

http://www.w3.org/2001/XMLSchema#string

Xia Jiang

http://www.w3.org/2001/XMLSchema#string

Yuki Haga

http://www.w3.org/2001/XMLSchema#string

P2860

Suppression of La antigen exerts potential antiviral effects against hepatitis A virus

Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha

Silencing of hepatitis A virus infection by small interfering RNAs

Small Interfering RNA Targeted to Hepatitis C Virus 5' Nontranslated Region Exerts Potent Antiviral Effect

Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis A virus (HAV) and implications for the polyprotein processing in HAV

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Functional significance of the interaction of hepatitis A virus RNA with glyceraldehyde 3-phosphate dehydrogenase (GAPDH): opposing effects of GAPDH and polypyrimidine tract binding protein on internal ribosome entry site function

Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells

La autoantigen suppresses IRES-dependent translation of the hepatitis A virus

Inhibition of hepatitis A virus replication in vitro by antiviral compounds

P304

205-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14218/JCTH.2015.00016

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282313789

http://www.w3.org/2001/XMLSchema#string

P698

26623267

http://www.w3.org/2001/XMLSchema#string

P921

P932

4663202

http://www.w3.org/2001/XMLSchema#string